USPTO serial 79152214
MACS
Reviewed by CopyMark Law Group
Reg. 4853118Status 706Registered
- Filing date
- Status date
- Registration date
- Nov 17, 2015
- Examiner
- HUSSAIN, TASNEEM
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with MACS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
DE
DE
DE
Bergisch Gladbach, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter S. Sloane
Peter S. Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical preparations for industrial, scientific and diagnostic purposes, other than for medical purposes, namely, chemical preparations for use in industry and biological preparation for use in cell cultures other than for medical or veterinary use; chemical products, namely, chemical additives for use in separation processes for biological materials; biochemical, chemical and diagnostic reagents for cell separation for scientific purposes, labelling biochemical, chemical and diagnostic reagents for scientific use; reagents, namely, biochemical, chemical and diagnostic reagents for non-medical purposes; media, namely, cell culture media for growing cells for use in scientific research; substances and constituent parts, namely, cytokines and growth factors, small molecules, proteins and serum fractions, for preparing media, all being used in industry and science and for use in medical laboratories; biochemical, chemical and diagnostic reagents for non-medical purposes for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemical and biological material; biochemical, chemical and diagnostic reagents for non-medical purposes featuring magnetic beads; antibody biochemical, chemical and diagnostic reagents other than for medical or veterinary purposes; buffer solutions and biochemical, chemical and diagnostic reagents for non-medical purposes for use with laboratory apparatus, in particular separation apparatus, analysis apparatus, reactors and imaging apparatus; biochemical, chemical and diagnostic reagents for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof other than for medical or veterinary purposes, namely, buffer solutions for passaging, processing and storing of cells, cell stimulating and modifying agents such as antigens, peptides and nucleotides, extracellular matrices and carrier materials for cell culture; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; culture media, cell culture media, freezing media, contrast media, contrast media for in-vivo imaging, all being for scientific research purposes; biochemical and chemical and diagnostic reagents for use in biotechnology, biological processing operations and the biotechnological industry for non-medical purposes | ACTIVE | — |
| 005 | Pharmaceutical, medical and veterinary preparations and preparations for pharmaceutical, medical and veterinary science, namely, diagnostic preparations for medial and veterinary use for the purpose of early recognition or characterization of diseases; pharmaceutical and other preparations, namely, diagnostic preparations for medial and veterinary use for the purpose of early recognition or characterization of diseases; reagents, media, substances in the nature of buffering solutions and components in the nature of growth factors, vitamins, and other additives for the preparation of media, all for medical or veterinary diagnostic use; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of biological material, all being for medical or veterinary diagnostic purposes; reagents featuring magnetic beads, antibody reagents, all being for medical or veterinary diagnostic purposes; buffer solutions in the nature of physiological salt solutions and for medical diagnostics; medical diagnostic reagents for use with medical apparatus, in particular separation apparatus, analyzing apparatus, reactors and imaging apparatus; medical diagnostic reagents for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof, all being for medical or veterinary purposes; diagnostic preparations and reagents for medical and veterinary use; culture media for use in cultivation and maturation of stem cells, tissue cells, or immune cells for medical purposes; cell culture media for cultivating microorganism, freezing media for use in in-vitro fertilization consisting primarily of sperm freezing medium and to store blood products, contrast media for use with cytometry equipment, and contrast media for in-vivo imaging, all being for medical and veterinary purposes; pharmaceutical preparations, in particular pharmaceutical preparations for cellular therapy treatment of cancer, autoimmunity, infection and inflammation and other tissue-based diseases as well as in the field of immunology, dermatology, neuroscience and cardiovascular research; chemical, biological and biochemical preparations for therapeutic treatment of cancer, autoimmunity, infection and inflammation and other tissue-based diseases as well as in the field of immunology, dermatology, neuroscience and cardiovascular research | ACTIVE | — |
| 009 | Scientific apparatus and instruments, namely, spectrometers, apparatus and columns for the automated cell separation and isolation, cytometry instruments; optical apparatus and instruments, namely, optical mirrors and screening apparatus in the nature of a device to screen data resulting from cell separation processes for the purpose of further cell analysis consisting of a microscope, a lens and a display; measuring apparatus and instruments, namely, digitizers; apparatus for recording, transmission or reproduction of images; data processing apparatus; computer software for controlling and managing of blood and blood elements information; all of the aforesaid goods, solely for the separation and analysis of biological material; scientific, electric and electronic apparatus and instruments, namely, laboratory chemical reactors for conducting enzymatic reactions; laboratory apparatus, in particular cytometers for measuring the physical and chemical properties of cells and particles in suspensions; instruments and apparatus for biotechnological and scientific purposes, namely, chromatography columns for use in purification in the laboratory for use in the analysis of biological material; all of the foregoing not used in the oil and gas industry | ACTIVE | — |
| 010 | Apparatus for magnetic cell separation for medical purposes for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; tube sets composed of blood collecting tube or drainage tubes for medical purposes; analysis columns for medical purposes, for blood analysis; cell culture apparatus for medical use, namely, cell culture sacks, pouches, bags, films, tubes and connecting pieces for cryopreservation; instruments and apparatus for medical purposes for use in surgery and medical diagnosis and therapy, namely, instruments for the medical diagnosis in the fields of cancer or other tissue-based diseases as well as cytology and other cell-based diseases; accessories and replacement parts for the aforesaid goods, namely, medical guide wires and parts and fittings therefor | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific, research, analysis and testing in the field of cell separation and isolation; Scientific and technological services, namely, research and design in the field of biotechnology; industrial research in the field of histology; design and development of computer hardware and software for analysis; all of the aforesaid services for and in connection with the analysis of biological and biochemical material, in particular of cell material for biological and medical research and therapy; medical, pharmaceutical and biotechnological research laboratories services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named MACS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Oct 28, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Oct 20, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 1, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 18, 2024 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 4, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 14, 2022 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| May 14, 2022 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| May 11, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 28, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Nov 17, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 20, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 5, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 8, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 26, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 26, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 17, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 17, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 1, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 12, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 12, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 12, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 24, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 24, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 21, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 21, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jul 21, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 21, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 21, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 6, 2015 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 6, 2015 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 6, 2015 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 1, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 1, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 1, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 17, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 3, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 2, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 2, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 2, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 1, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 29, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 18, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |